logo

For the Inventor, By the Inventor

Raritan, NJ, United States of America

Ortho Pharmaceutical Corporation


USPTO Granted Patents = 377



Trademarks = 8

Forward Citations = 5,673

Loading Chart...
Loading Chart...

257 inventors (with patents filed for the assignee):

goldMedal Gideon Goldstein (50 out of 81 patents)

silverMedal Michael P Wachter (41 out of 73 patents)

bronzeMedal Patrick C Kung (33 out of 34 patents)

4.  Jeffery B Press (30 out of 40 patents)

5.  Ramesh M Kanojia (29 out of 32 patents)

6.  Victor T Bandurco (19 out of 23 patents)

7.  Zoltan G Hajos (19 out of 19 patents)

8.  William V Murray (17 out of 49 patents)

9.  Robert H Chen (17 out of 33 patents)

10.  Robert Falotico (16 out of 48 patents)

11.  Pauline J Sanfilippo (16 out of 21 patents)

12.  Charles F Schwender (16 out of 51 patents)

13.  George Heavner (15 out of 18 patents)

14.  Lawrence E Lambelet, Jr (14 out of 17 patents)

15.  Donald W Combs (13 out of 17 patents)


Core Competencies:
Liquid Phase Peptide Synthesis
Pulmonary Surfactant
Histamine Receptor
Anti-Inflammatory Compounds
Erythropoietin
Oral Contraceptive Regimen
Lyophilized Imaging Agents
Transgenic Mice
Thrombin Related Treatments
Antimicrobial Agents
Peptidyl Heterocycles
Dosage Regimen Container

377 patents:

1. 8217142 - Liquid phase peptide synthesis of KL-4 pulmonary surfactant (2012-07-10),
2. 6635633 - Substituted pyrazoles (2003-10-21),
3. 6492490 - Liquid phase peptide syntheses of KL-4 pulmonary surfactant (2002-12-10),
4. 6437100 - DNA encoding a human histamine receptor of the H3 subtype (2002-08-20),
5. 6423550 - Home oral fluid sample collection device and package for mailing of such device (2002-07-23),
6. 6413743 - DNA encoding a human histamine receptor of the H3 subtype (2002-07-02),
7. 6372779 - Anti-inflammatory compounds (2002-04-16),
8. 6251956 - Combination progestin oral contraceptive regimen (2001-06-26),
9. 6235710 - Spray dried erythropoietin (2001-05-22),
10. 6221608 - Methods for identifying erythropoietin receptor binding protein (2001-04-24),
11. 6171868 - Method of sampling bodily fluids (2001-01-09),
12. 6136559 - DNA encoding as human histamine receptor of the H3 subtype (2000-10-24),
13. 6120795 - Manufacture of liposomes and lipid-protein complexes by ethanolic (2000-09-19),
14. 6071537 - Anticonvulsant derivatives useful in treating obesity (2000-06-06),
15. 6069254 - Carboxamide derivatives of piperidine for the treatment of thrombosis (2000-05-30),
Ortho Pharmaceutical Corporation is a leading pharmaceutical company that specializes in the development and manufacturing of innovative healthcare products. With a commitment to improving patient outcomes, Ortho Pharmaceutical Corporation offers a wide range of medications and therapies across various therapeutic areas. The company focuses on research and development to introduce new and effective treatments for various diseases and conditions. Visit our website to learn more about our products, services, and commitment to excellence.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

377 Patents

#1 in Raritan, NJ

#64 in New Jersey

#1,181 in US

#2,372 in the World

...
Raritan, NJ, United States of America

Ortho Pharmaceutical Corporation

Forward Citations = 5,673

257 inventors:

goldMedal Gideon Goldstein (50 out of 81 patents)

silverMedal Michael P Wachter (41 out of 73 patents)

bronzeMedal Patrick C Kung (33 out of 34 patents)

4.  Jeffery B Press (30 out of 40 patents)

5.  Ramesh M Kanojia (29 out of 32 patents)

Please report any incorrect information to support@idiyas.com
Loading…